Shanghai - Delayed Quote CNY
Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
8.12
+0.07
+(0.87%)
At close: 3:00:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
-12,886.30
44,552.12
-78,373.92
508,839.39
174,479.18
Operating Cash Flow
--
44,552.12
-78,373.92
508,839.39
174,479.18
Investing Cash Flow
-329,026.20
-253,986.38
-332,218.59
-282,283.29
-311,762.62
Financing Cash Flow
150,430.92
83,011.38
363,584.18
-301,786.27
537,753.72
End Cash Position
494,222.95
453,156.71
578,764.21
614,263.46
689,257.18
Capital Expenditure
-340,238
-266,224.55
-472,184.49
-303,878.92
-153,166.43
Issuance of Debt
1,216,093.09
2,278,543.95
1,694,889.26
1,128,679.72
1,582,230
Repayment of Debt
-2,056,978.95
-2,430,633.10
-1,146,817.92
-1,283,540
-1,468,542.25
Free Cash Flow
-353,124.30
-221,672.43
-550,558.40
204,960.47
21,312.75
12/31/2020 - 3/9/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade